Gauss Surgical, now a part of Stryker

Gauss Surgical, based in Menlo Park, California, is a medical device company that specializes in artificial intelligence technology for real-time blood loss monitoring during surgery. Founded in 2011, the company developed Triton™, a computer vision-powered software platform that accurately quantifies blood loss by analyzing images of surgical sponges, towels, and fluid canisters. This innovative technology is accessible on mobile devices, making it user-friendly in clinical settings. Gauss Surgical's mission is to enhance diagnostic accuracy, patient safety, and clinical outcomes. Triton was the first computer vision software for surgical use to receive De Novo clearance from the FDA in 2014. The platform has gained widespread adoption among health systems in the U.S. and has received recognition for its design and innovation. The company also has plans to develop a digital smartphone platform for rapid coronavirus detection, which will be spun out as a separate entity following its acquisition by Stryker in 2021.

• Employees 7
• Founded 2011
• Total Funding $46099997